top of page

Новини

Published at: 2023-05-25

Stablepharma and Partner BB-NCIPD Ltd (Bul Bio) sign a second exclusive supply agreement to develop a fridge-free Tetanus mono vaccine.



Stablepharma and BB SPVX06 Press Release Final (1)
.docx
Изтегляне на DOCX • 54KB




Stablepharma and Partner Bul Bio sign a second exclusive supply agreement
bottom of page